2007 Physician Access Study with Tracking Against 2006 Findings
As sales representatives continue to experience difficulty getting in front of physicians, MD Analytics is pleased to announce its call for participation in the 2007 Physician Access Study. Participate in this study to better understand key factors for successful representative visits and competitive strategies and tactics that physicians most respond to. More information.
2007 Continuing Healthcare Education Study
Building off the 2005 CHE study findings, the 2007 study will benefit you by providing insight into current CHE format and content preferences. It will also uncover the therapeutic areas and specific topics in greatest need of CHE. More information.
2007 Medication Non-Adherence Study
Medication is prescribed with the expectation that it will be taken exactly as specified, but non-adherence, the failure to take drugs on time in the dosages prescribed, occurs frequently and unpredictably and can be dangerous, costly and as high as 60%. More information.
Metabolic Syndrome Study
Between 33 and 40% of the Canadian population has some form of Metabolic Syndrome. What are the implications for diagnosis and treatment? Find out with the syndicated study on Metabolic Syndrome. More information.
Update on the COX-2 Inhibitor and NSAID Environment in Canada
This new syndicated study will explore ongoing market changes since the Vioxx withdrawal in September, 2004. More information.
Winter Season Mental Fitness Study
How do Canadians react to holiday stressors and how does the healthcare community provide support. This landmark study was conducted in partnership with the Canadian Mental Health Association and identifies the incidence, prevalence and severity of winter holiday stress, anxiety and depression symptoms. More information.
Promotional Effectiveness Study
How can you reach GP/FPs amidst competing information demands? How effective is your non-salesforce promotional spend? Find out what’s working and identify the most effective promotional tactics for today’s rapidly evolving communication environment. More Information.
2006 Sampling Study
Physician samples are likely one of your major marketing investments – but is your sample program driving accessibility and prescription writing? This study builds on the 2005 Sampling Study to track changes and dive deeper into sub-topics such as alignment of sample supply with physician needs by therapeutic class and enhancing understanding of the influence samples have on physician prescribing. More information.
Interchangeability Study
How is interchangeability impacting prescription choices and final dispensing decisions? This study dives into the topic of drug interchangeability which has been vigorously debated in Bill 102. Better understand what happens to your prescriptions after they leave a physician’s office, uncover the key factors related to drug choice at the time of prescription writing and at the time of dispensing by pharmacists. More information.
2006 Physician Access Study
The time physicians can spend away from patients has decreased making their willingness to see pharmaceutical sales representatives more challenging. Participate in this study to gain insights on the criteria physicians use to see sales representatives so your company can modify its access strategies. More information.
Factors in Successful Continuing Healthcare Education (CHE)
Ideal for CHE professionals seeking rich insights on what works and doesn’t work from the physicians’ point of view. Discover key motivators and deterrents as inputs to your program and materials design. More information.
Best Practices in Pharmaceutical Sampling (2005)
Designed for pharmaceutical marketers to determine the effectiveness of sampling as a physician access tactic and the influence sampling has on physician prescribing behavior. Gain key insights to optimize your program. More information.
Medication Non-Adherence
Find out why it occurs and learn what physicians recommend be done about it. Includes disease areas most affected and insights on how physicians manage non-adherence. More information.
NSAID Market Dynamics
Insights on physician reactions to COX-2 and NSAID safety concerns and side effects; management of arthritic patients; market dynamics and prescribing behavior changes.
Impact of Vioxx Withdrawal
Are you affected? You’ll want to understand the physician, rheumatologist and internist changes to management of arthritic and acute pain due to COX-2 inhibitor regulatory warnings.
FREE Newsletter with Study Alerts
Stay abreast of upcoming syndicated study opportunities and benefit from lower research costs, targeted content value and innovative ways to get answers to questions on key topics. Opt. in today
Purchase Information
Save with multiple study purchases. For more information contact your account manager, contact us or call 1-866-617-0741.
|